Simulations Plus, Inc | Modeling & Simulation Software | Consulting Services for Pharmaceutical Research

Sign up in 60 seconds for an evaluation

Questions? Call +1 661.723.7723

Latest Publications

In silico modeling to predict drug-induced phospholipidosis
Read More

Predicting Pharmacokinetic Profiles Using In Silico Derived Parameters.
Read More

Events

DDI 2013: 4th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions at Marbach Castle, Germany - May 26-28
Read More

RDD Europe 2013 - Respiratory Drug Delivery - in Berlin, Germany - May 21-24
Read More

News

Simulations Plus Software Used in Regulatory Submittals

LANCASTER, CA, May 14, 2013 – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discover...

Simulations Plus Announces Quarterly Cash Dividend Increase

LANCASTER, CA, April 26, 2013 – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discov...

	Media Center		Downloads		Testimonials		Events		Publications		Connect With Us

Simulations Plus, Inc. • 42505 10th Street West, Lancaster, California 93534-7059 • USA
Phone: +1 661.723.7723 • Fax: +1 661.723.5524 • Email: info@simulations-plus.com